As drug patents begin to expire, pharma is looking for ways to fill the pipelines and biotech drugs appear to be one of the hottest avenues to fill the pipelines, we recently saw Cougar Biotech purchased by J and J. One thing I think we forget about...
Filed under: Medically Related, Technology, My Commentaries, healthcare, Pharma, Biotech, R and D, Patents, Stocks, Intellectual property, Bristol-Myer Squibb, ImClone, trading